Gene editing company CRISPR Therapeutics (CRSP) made a basing pattern in the January-July time frame and the indicators support the potential for further price gains. Let's check out the charts.




Gene editing company CRISPR Therapeutics (CRSP) made a basing pattern in the January-July time frame and the indicators support the potential for further price gains. Let's check out the charts.
Like or not, this is classic bear market action playing out.
The charts don't look very appetizing for the spice company.
The charts show further declines ahead for the credit card company.
When one of the last holdouts of the S&P 500 turns down the selloff is in full gear.
I'm not the only one who likes the tech behemoth. Bill Ackman believes Alphabet will be a leader in AI for years to come.
We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.
Email Real Money's Wall Street Pros for further analysis and insight
Already a Subscriber? Login
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login